Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GenNext Technologies logo — Revolutionizing protein higher order structural analysis

GenNext Technologies

Revolutionizing protein higher order structural analysis

Founded 2018 United States Half Moon Bay, United States 16 employees Non Equity Assistance Total: $7.00M Biopharma, Biotechnology

General Information

Company Name GenNext Technologies
Founded Year 2018
Location United States Half Moon Bay, United States
Employees 16
Industries Biopharma, Biotechnology
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with GenNext Technologies. To contact GenNext Technologies, visit gnxtech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GenNext Technologies compare?

A PDF of GenNext Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GenNext Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GenNext Technologies

GenNext Technologies is a biopharma and biotechnology startup with a mission to revolutionize protein higher order structural analysis. Since its establishment in 2016, the company has been dedicated to making structural biology more accessible by offering a range of products and services aimed at pharmaceutical researchers. GenNext Technologies' offerings include instrumentation, software, and services tailored to investigate biopharmaceutical structure, interactions, folding, aggregation, formulation, and delivery. The company's disruptive products have been designed to enhance structural biology-focused research, ultimately contributing to the acceleration of biopharmaceutical development and the improvement of therapeutic efficacy and safety. The growth and innovation of GenNext Technologies attracted the attention of investors, with the latest Non Equity Assistance investment coming in on 06 July 2022 from BioTools Innovator. GenNext Technologies' strong focus on addressing critical needs in the biopharmaceutical industry and its commitment to enabling advancements in structural biology have positioned it as an intriguing opportunity for venture capitalists seeking to support groundbreaking innovations in the field.

Business keywords: structural biology, biopharmaceutical, instrumentation, pharmaceutical, biopharmaceutical development, therapeutic efficacy, safety, protein analysis, formulation, structural analysis, interactions, revolutionary technology, innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
BioTools Innovator
BioTools Innovator
06 Jul 2022
Grant $7.00M 1
National Institutes of Health
28 Apr 2021

GenNext Technologies Alternatives & Competitors

View All Alternatives
GenNext Technologies vs
Proteolix
Proteolix United States

Biopharmaceutical company engaged in the development and commercialization of innovative therapies

Series C
12 employees
Biopharma, Biotechnology
GenNext Technologies vs
CLOVERNA
CLOVERNA Japan

RNA targeted drug discovery

1 employees
Biopharma, Biotechnology
GenNext Technologies vs
Complegen Inc
Complegen Inc

Innovative systems for groundbreaking discoveries in pharmaceuticals and agriculture.

Grant
3 employees
Biopharma, Biotechnology
View all alternatives

FAQ About GenNext Technologies

Revolutionizing protein higher order structural analysis
GenNext Technologies was founded in 2018.
GenNext Technologies is headquartered in Half Moon Bay, United States.
GenNext Technologies operates in Biopharma and Biotechnology. Its work centres on structural biology, biopharmaceutical, instrumentation and pharmaceutical.
GenNext Technologies has approximately 16 employees.
GenNext Technologies has completed 2 funding rounds, raising a total of $7.00M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to GenNext Technologies include Proteolix, CLOVERNA, Complegen Inc, Flexus Biosciences, Halo Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenNext Technologies and Proteolix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GenNext Technologies, https://bouncewatch.com/company/gennext-technologies, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes